Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2800 Clay Edwards Drive
North Kansas City, MO 64116Phone+1 816-691-1555
Education & Training
Texas A&M; Health Science Center College of MedicineClass of 1987
Publications & Presentations
PubMed
- 84 citationsPreclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous InflammationJordan S. Fridman, Peggy Scherle, Robert Collins, Timothy Burn, Claire L. Neilan
The Journal of Investigative Dermatology. 2011-09-01 - 332 citationsSelective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050Jordan S. Fridman, Peggy Scherle, Robert Collins, Timothy Burn, Yanlong Li
Journal of Immunology. 2010-05-01 - 64 citationsINCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support.Jun Li, Margaret Favata, Jennifer Kelley, Eian Caulder, Beth Thomas
Neoplasia. 2010-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
